Compare · CVS vs YI
CVS vs YI
Side-by-side comparison of CVS Health Corporation (CVS) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVS and YI operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- CVS is the larger of the two at $118.41B, about 4356.0x YI ($27.2M).
- CVS has been more active in the news (9 items in the past 4 weeks vs 4 for YI).
- CVS has more recent analyst coverage (25 ratings vs 0 for YI).
- Company
- CVS Health Corporation
- 111 Inc.
- Price
- -
- -
- Market cap
- $118.41B
- $27.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 9
- 4
- Recent ratings
- 25
- 0
CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest CVS
- CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
- MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards
- Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
- CVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area
- CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
- CVS Health to hold third quarter 2026 earnings conference call
- Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
- CVS Health declares quarterly dividend
- As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide
- Aetna expands bundled oncology prior authorizations, easing provider burden and accelerating member access to care
Latest YI
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $37,622 worth of RSUs (180,880 units at $0.21) (SEC Form 4) to cover taxes
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Establishment of the Special Committee
- Director Chen Yang Luke sold $30,760 worth of RSUs (142,760 units at $0.22) and was granted 594,222 units of RSUs (SEC Form 4) (for tax liability)
- SEC Form 6-K filed by 111 Inc.
- SEC Form 6-K filed by 111 Inc.
- 111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
- 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $22,840 worth of RSUs (98,760 units at $0.23) (SEC Form 4) to cover withholding tax
- Director Sun Jian David was granted 810,271 units of RSUs and sold $92,749 worth of RSUs (397,060 units at $0.23) (SEC Form 4) (withholding tax)